CSPC Innovation Pharmaceutical: Legal Opinion of Beijing Junzejun Law Firm on Witnessing the 2024 First Extraordinary General Meeting of Shareholders of Shiyao Innovative Pharmaceutical Co., Ltd.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.